BioAge Labs (BIOA) Depreciation & Amortization (CF) (2023 - 2026)

BioAge Labs has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $63000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $63000.0, up 70.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $319000.0 (up 0.63% YoY), and the FY2025 annual result was $200000.0, changed 0.0% from the prior year.
• Depreciation & Amortization (CF) came in at $63000.0 for Q1 2026 at BioAge Labs, up from $56000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q3 2023 to a low of $33000.0 in Q1 2024.
• The 4-year median for Depreciation & Amortization (CF) is $80000.0 (2024), against an average of $77090.9.
• Across the five-year window, Depreciation & Amortization (CF) slumped 30.0% in 2025 and surged 70.27% in 2026, its largest moves.
• BioAge Labs' Depreciation & Amortization (CF) stood at $79000.0 in 2023, then rose by 1.27% to $80000.0 in 2024, then dropped by 30.0% to $56000.0 in 2025, then climbed by 12.5% to $63000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $63000.0 (Q1 2026), $56000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.